<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Bras Pneumol</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Bras Pneumol</journal-id>
      <journal-title-group>
        <journal-title>Jornal Brasileiro de Pneumologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1806-3713</issn>
      <issn pub-type="epub">1806-3756</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Pneumologia e Tisiologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26176527</article-id>
      <article-id pub-id-type="pmc">4541765</article-id>
      <article-id pub-id-type="doi">10.1590/S1806-37132015000004247</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Formation of multiple pulmonary nodules during treatment with leflunomide<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Yoshikawa</surname>
            <given-names>Gilberto Toshikawa</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dias</surname>
            <given-names>George Alberto da Silva</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fujihara</surname>
            <given-names>Satomi</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Silva</surname>
            <given-names>Luigi Ferreira e</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cruz</surname>
            <given-names>Lorena de Britto Pereira</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fuzii</surname>
            <given-names>Hellen Thais</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Koyama</surname>
            <given-names>Roberta Vilela Lopes</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1.</label>Senior Assistant Professor. Federal University of Par&#xE1;, Bel&#xE9;m, Brazil</aff>
      <aff id="aff2"><label>2.</label>Medical Student. Federal University of Par&#xE1;, Bel&#xE9;m, Brazil</aff>
      <aff id="aff3"><label>3.</label>Junior Assistant Professor. Federal University of Par&#xE1;, Bel&#xE9;m, Brazil</aff>
      <aff id="aff4"><label>4.</label>Adjunct Professor II. Federal University of Par&#xE1;, Bel&#xE9;m, Brazil</aff>
      <author-notes>
        <corresp id="c01"><bold>Correspondence to:</bold> Gilberto Yoshikawa. Avenida Senador Lemos, 443, Edif&#xED;cio Village Executive, sala 908/909, CEP 66050-000, Bel&#xE9;m, PA, Brasil. Tel. 55 91 3241-7905. E-mail: <email>gyoshikawa@uol.com.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>May-Jun</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>May-Jun</season>
        <year>2015</year>
      </pub-date>
      <volume>41</volume>
      <issue>3</issue>
      <fpage>281</fpage>
      <lpage>284</lpage>
      <history>
        <date date-type="received">
          <day>08</day>
          <month>5</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>24</day>
          <month>11</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Pulmonary involvement is one of the extra-articular manifestations of rheumatoid arthritis and can be due to the disease itself or secondary to the medications used in order to treat it. We report the case of a 60-year-old woman who had been diagnosed with rheumatoid arthritis and developed multiple pulmonary nodules during treatment with leflunomide.</p>
      </abstract>
      <kwd-group>
        <kwd>Arthritis, rheumatoid</kwd>
        <kwd>Immunosuppressive agents</kwd>
        <kwd>Rheumatoid nodule</kwd>
        <kwd>Lung</kwd>
      </kwd-group>
      <counts>
        <fig-count count="6"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="16"/>
        <page-count count="4"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Rheumatoid arthritis (RA) is an autoimmune disease of unknown etiology that is characterized by symmetric polyarthritis and can lead to joint deformity and destruction.<sup>(</sup>
<xref rid="B01" ref-type="bibr">1</xref>
<sup>,</sup>
<xref rid="B02" ref-type="bibr">2</xref>
<sup>)</sup> When RA involves other organs besides the joints, there is an increase in morbidity and severity, and life expectancy can be reduced by 5 to 10 years.<sup>(</sup>
<xref rid="B01" ref-type="bibr">1</xref>
<sup>)</sup>
</p>
      <p>Pulmonary involvement in RA was first described by Ellman and Ball,<sup>(</sup>
<xref rid="B03" ref-type="bibr">3</xref>
<sup>)</sup> who reported diffuse pulmonary fibrosis in three patients with RA. Since then, the association between pulmonary involvement and RA has been described by several authors. The risk factors for pulmonary involvement include middle age, male gender, severe erosive arthritis, high titers of rheumatoid factor, subcutaneous nodules, smoking, genetic predisposition (HLA-DRB1), and other extra-articular manifestations of RA.<sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>,</sup>
<xref rid="B05" ref-type="bibr">5</xref>
<sup>)</sup>
</p>
      <p>Pulmonary involvement is a severe complication of RA and can manifest as upper airway disease, interstitial lung disease, pleural effusion, bronchiolitis obliterans, fibrosing alveolitis, pulmonary rheumatoid nodules, bronchiectasis, Caplan syndrome, pulmonary hemorrhage, organizing pneumonia, vasculitis, and pulmonary infections.<sup>(</sup>
<xref rid="B06" ref-type="bibr">6</xref>
<sup>-</sup>
<xref rid="B09" ref-type="bibr">9</xref>
<sup>)</sup>
</p>
    </sec>
    <sec>
      <title>Case report</title>
      <p>A 60-year-old White female librarian, who had been born and raised in the city of Bel&#xE9;m, Brazil, presented with an approximately 10-year-history of RA, as defined on the basis of the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for RA. At the time of diagnosis, she was started on methotrexate, the dose of which was progressively increased to 15 mg/week. Subsequently, methotrexate was discontinued because of gastrointestinal intolerance, and, at that time, it was decided to start the patient on leflunomide (20 mg/day) and deflazacort (12 mg/day). During the treatment period, the patient had joint improvement and, on her own initiative, reduced her leflunomide dose from 20 mg/day to 20 mg/every other day.</p>
      <p>A chest X-ray performed 8 years previously to screen the patient for fractures after chest trauma had shown a pulmonary nodule in the right lung base. A chest X-ray performed before the patient was started on leflunomide had been normal. On that basis, the patient sought a pulmonologist, who requested further investigation. The results of the ancillary tests were as follows: blood workup, no changes; ESR, 65 mm/h; levels of transaminase and nitrogenous compounds, normal; antinuclear factor, negative; PCR, 6.2 mg/L; serology for viral hepatitis, negative; rheumatoid factor, positive (443 IU/mL); perinuclear and cytoplasmic antineutrophil cytoplasmic antibody (p-ANCA and c-ANCA), negative on several occasions; bronchoscopy results, normal; BAL microscopy, negative for bacteria; BAL cultures, negative; and BAL cytology, low cellularity and autolytic pattern. A CT scan of the chest showed multiple cavitary pulmonary nodules predominantly in the left lung base (<xref ref-type="fig" rid="f01">Figure 1</xref>). A biopsy of a peripheral nodule revealed an acute suppurative inflammatory process with necrosis. At the time, it was decided that the patient should undergo clinical and radiological follow-up.</p>
      <p>
<fig id="f01" orientation="portrait" position="float"><label>Figure 1.</label><caption><title>CT scan of the chest showing cavitary nodular opacities.</title></caption><graphic xlink:href="1806-3713-jbpneu-41-03-00281-gf01"/></fig>
</p>
      <p>After a five-month follow-up of the pulmonary nodules, the patient developed dyspnea on exertion accompanied by dry cough, but no fever. Another bronchoscopy revealed laryngitis and a nodule on the right vocal fold. The tracheobronchial tree was endoscopically normal; BAL was negative for AFB, BAL microscopy revealed gram-negative bacilli (<italic>Klebsiella pneumoniae</italic> and <italic>Pseudomonas fluorescens</italic> were isolated by using an automated culture system), BAL cultures for mycobacteria and fungi were negative, and BAL cytology revealed no neoplastic cells. At that time, the patient was started on antibiotic therapy with clindamycin and fluconazole. After bronchoscopy showed negative BAL fluid cultures, prednisone (40 mg/day) was commenced in an attempt to stabilize her condition. However, despite the therapeutic approach used, another CT scan of the chest revealed increased pulmonary nodules (<xref ref-type="fig" rid="f02">Figure 2</xref>). At that point, the patient was referred to the city of S&#xE3;o Paulo, Brazil, for evaluation. A lung biopsy (<xref ref-type="fig" rid="f03">Figure 3</xref>) by video-assisted thoracoscopy showed a chronic inflammatory lesion, with an exudative center, adjacent to the lung parenchyma (disrupted by lymphocytic vasculitis), as well as a central cavitation filled with fibrinoleukocytic exudate and a lymphocytic infiltrate surrounded by granulation tissue. The results of AFB and fungal testing were negative, as was the result of neoplastic cell testing. In view of this result, which ruled out neoplastic and infectious disease, it was decided to discontinue leflunomide. Systemic corticosteroid therapy was continued, and azathioprine (1 mg/kg/day) was commenced. Six months after leflunomide was discontinued, the pulmonary nodules disappeared. At this writing, the patient was free of disease activity, was taking abatacept (500 mg/month), and had been off systemic corticosteroid therapy for over a year.</p>
      <p>
<fig id="f02" orientation="portrait" position="float"><label>Figure 2.</label><caption><title>CT scan of the chest showing a nodular opacity adjacent to the pleural surface, located in the right lower lobe.</title></caption><graphic xlink:href="1806-3713-jbpneu-41-03-00281-gf02"/></fig>
</p>
      <p>
<fig id="f03" orientation="portrait" position="float"><label>Figure 3.</label><caption><title>Lung biopsy. In A, fibrin and collagen deposition (red arrow) surrounded by cell debris (dark arrow), with an area of necrosis. In B, inflammatory infiltrate with multinucleated cells (dark arrow) and central necrosis.</title></caption><graphic xlink:href="1806-3713-jbpneu-41-03-00281-gf03"/></fig>
</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Pulmonary rheumatoid nodules are extra-articular manifestations of RA.<sup>(</sup>
<xref rid="B02" ref-type="bibr">2</xref>
<sup>,</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>)</sup> The prevalence of these nodules is variable: they are detected on chest X-ray in only 1% of RA patients, whereas they are identified on chest HRCT in up to 20-22% and are detected by open lung biopsy in 32%.<sup>(</sup>
<xref rid="B07" ref-type="bibr">7</xref>
<sup>,</sup>
<xref rid="B10" ref-type="bibr">10</xref>
<sup>-</sup>
<xref rid="B12" ref-type="bibr">12</xref>
<sup>)</sup>
</p>
      <p>Pulmonary rheumatoid nodules can be single or multiple and range from a few millimeters to 7 cm in diameter. They are mostly asymptomatic or produce few symptoms, although they can cause cough and bloodstained sputum, and tend to involve both lungs. They occur at the periphery of the lung, just beneath the pleura, and can cavitate in approximately one third of cases, causing hemoptysis, bronchopleural fistula, spontaneous pneumothorax, secondary infection, and abscess.<sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>,</sup>
<xref rid="B10" ref-type="bibr">10</xref>
<sup>,</sup>
<xref rid="B13" ref-type="bibr">13</xref>
<sup>)</sup>
</p>
      <p>The appearance of pulmonary nodules in RA patients is a diagnostic problem, and the possibilities of malignancy and tuberculosis should be ruled out.<sup>(</sup>
<xref rid="B10" ref-type="bibr">10</xref>
<sup>,</sup>
<xref rid="B13" ref-type="bibr">13</xref>
<sup>)</sup> Nodules due to lung cancer are characteristically greater than 10 mm in diameter and have irregular borders. Metastases can also appear as multiple nodules in the lungs; however, no primary cancer was found in the case reported here.<sup>(</sup>
<xref rid="B11" ref-type="bibr">11</xref>
<sup>,</sup>
<xref rid="B12" ref-type="bibr">12</xref>
<sup>,</sup>
<xref rid="B14" ref-type="bibr">14</xref>
<sup>)</sup>
</p>
      <p>Other diagnostic possibilities include mycobacterial and fungal infections, which can manifest as nodules; however, the absence of systemic symptoms is rare.<sup>(</sup>
<xref rid="B11" ref-type="bibr">11</xref>
<sup>)</sup>
</p>
      <p>A relevant aspect in the case reported here is that the pulmonary nodules were likely related to the use of leflunomide, since there are several arguments in favor of this hypothesis: the patient in question had a long-term history of RA and had shown no signs of pulmonary involvement prior to treatment with leflunomide; pulmonary rheumatoid nodules can appear during treatment with leflunomide; and there have been reports of peripheral and/or pulmonary rheumatoid nodules in patients undergoing treatment with leflunomide.<sup>(</sup>
<xref rid="B08" ref-type="bibr">8</xref>
<sup>,</sup>
<xref rid="B15" ref-type="bibr">15</xref>
<sup>,</sup>
<xref rid="B16" ref-type="bibr">16</xref>
<sup>)</sup>
</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="supported-by">
        <label>*</label>
        <p>Study carried out at the Federal University of Par&#xE1;, Bel&#xE9;m, Brazil.</p>
      </fn>
      <fn fn-type="supported-by">
        <p>Financial support: None.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>FY</given-names>
            </name>
            <name>
              <surname>Mo</surname>
              <given-names>XB</given-names>
            </name>
            <name>
              <surname>Qiu</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Lei</surname>
              <given-names>SF</given-names>
            </name>
          </person-group>
          <article-title>Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update</article-title>
          <source>Pharmacogenomics</source>
          <year>2014</year>
          <volume>15</volume>
          <issue>4</issue>
          <fpage>551</fpage>
          <lpage>566</lpage>
          <pub-id pub-id-type="doi">10.2217/pgs.14.25</pub-id>
          <pub-id pub-id-type="pmid">24624921</pub-id>
        </element-citation>
      </ref>
      <ref id="B02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Atzeni</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Boiardi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sall&#xEC;</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Benucci</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sarzi-Puttini</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis</article-title>
          <source>Expert Rev Clin Immunol</source>
          <year>2013</year>
          <volume>9</volume>
          <issue>7</issue>
          <fpage>649</fpage>
          <lpage>657</lpage>
          <pub-id pub-id-type="doi">10.1586/1744666X.2013.811173</pub-id>
          <pub-id pub-id-type="pmid">23899235</pub-id>
        </element-citation>
      </ref>
      <ref id="B03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ellman</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ball</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Rheumatoid disease with joint and pulmonary manifestations</article-title>
          <source>Br Med J</source>
          <year>1948</year>
          <volume>2</volume>
          <issue>4583</issue>
          <fpage>816</fpage>
          <lpage>820</lpage>
          <pub-id pub-id-type="doi">10.1136/bmj.2.4583.816</pub-id>
          <pub-id pub-id-type="pmid">18890308</pub-id>
        </element-citation>
      </ref>
      <ref id="B04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chanin</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Vallejo-Manzur</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sternbach</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Fromm</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Varon</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary manifestations of rheumatoid arthritis</article-title>
          <source>Hosp Physician</source>
          <year>2001</year>
          <volume>37</volume>
          <issue>7</issue>
          <fpage>23</fpage>
          <lpage>28</lpage>
        </element-citation>
      </ref>
      <ref id="B05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Ede</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>den Broeder</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wagenaar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>van Riel</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Creemers</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Etanercept-related extensive pulmonary nodulosis in a patient with rheumatoid arthritis</article-title>
          <source>J Rheumatol</source>
          <year>2007</year>
          <volume>34</volume>
          <issue>7</issue>
          <fpage>1590</fpage>
          <lpage>1592</lpage>
          <pub-id pub-id-type="pmid">17610313</pub-id>
        </element-citation>
      </ref>
      <ref id="B06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karadag</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Polatli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Senturk</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kacar</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cildag</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Cavitary necrobiotic nodule imitating malignant lung disease in a patient without articular manifestations of rheumatoid arthritis</article-title>
          <source>J Clin Rheumatol</source>
          <year>2003</year>
          <volume>9</volume>
          <issue>4</issue>
          <fpage>246</fpage>
          <lpage>252</lpage>
          <pub-id pub-id-type="doi">10.1097/01.rhu.0000081260.50171.bf</pub-id>
          <pub-id pub-id-type="pmid">17041465</pub-id>
        </element-citation>
      </ref>
      <ref id="B07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dawson</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Graham</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Lung disease in patients with rheumatoid arthritis</article-title>
          <source>CPD Rheumatol</source>
          <year>2002</year>
          <volume>3</volume>
          <issue>2</issue>
          <fpage>38</fpage>
          <lpage>42</lpage>
        </element-citation>
      </ref>
      <ref id="B08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gauhar</surname>
              <given-names>UA</given-names>
            </name>
            <name>
              <surname>Gaffo</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Alarc&#xF3;n</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary manifestations of rheumatoid arthritis</article-title>
          <source>Semin Respir Crit Care Med</source>
          <year>2007</year>
          <volume>28</volume>
          <issue>4</issue>
          <fpage>430</fpage>
          <lpage>440</lpage>
          <pub-id pub-id-type="doi">10.1055/s-2007-985664</pub-id>
          <pub-id pub-id-type="pmid">17764060</pub-id>
        </element-citation>
      </ref>
      <ref id="B09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosa</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Paula</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Bonfante</surname>
              <given-names>HLM</given-names>
            </name>
            <name>
              <surname>Bonfante</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Areal</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Bai&#xE3;o</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
          <article-title>Accelerated nodulosis in rheumatoid arthritis during Leflunomide therapy [Article in Portuguese].</article-title>
          <source>Rev Bras Reumatol</source>
          <year>2007</year>
          <volume>47</volume>
          <issue>3</issue>
          <fpage>228</fpage>
          <lpage>231</lpage>
          <pub-id pub-id-type="doi">10.1590/S0482-50042007000300015</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burke</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Carrington</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Grinnan</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary nodules and rheumatoid factor in the absence of arthritis</article-title>
          <source>Chest</source>
          <year>1977</year>
          <volume>72</volume>
          <issue>4</issue>
          <fpage>538</fpage>
          <lpage>540</lpage>
          <pub-id pub-id-type="doi">10.1378/chest.72.4.538</pub-id>
          <pub-id pub-id-type="pmid">908228</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Espinoza-Poblano</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Betancourt-Hern&#xE1;ndez</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Canizales-Cobos</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Careaga-Reyna</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Esparza-Pantoja</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>N&#xF3;dulos pulmonares necrobi&#xF3;ticos en ausencia de artritis reumatoide. Reporte de un caso</article-title>
          <source>Neumol Cir Torax</source>
          <year>2000</year>
          <volume>59</volume>
          <issue>4</issue>
          <fpage>109</fpage>
          <lpage>111</lpage>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>Case records of the Massachusetts General Hospital</collab>
          </person-group>
          <article-title>Weekly clinicopathological exercises. Case 10-2001. A 53-year-old woman with arthritis and pulmonary nodules</article-title>
          <source>N Engl J Med</source>
          <year>2001</year>
          <volume>344</volume>
          <issue>13</issue>
          <fpage>997</fpage>
          <lpage>1004</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM200103293441308</pub-id>
          <pub-id pub-id-type="pmid">11274627</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Kairalla</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <chapter-title>Manifesta&#xE7;&#xF5;es pulmonares das doen&#xE7;as do tecido conectivo (DTC)</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Zamboni</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>CAC</given-names>
            </name>
          </person-group>
          <source>Pneumologia - Diagn&#xF3;stico e Tratamento.</source>
          <publisher-loc>S&#xE3;o Paulo</publisher-loc>
          <publisher-name>Editora Atheneu</publisher-name>
          <fpage>235</fpage>
          <lpage>244</lpage>
          <year>2006</year>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alu&#x161;&#xED;k</surname>
              <given-names>&#x160;</given-names>
            </name>
            <name>
              <surname>Fanta</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Eis</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Mandys</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Pavlicek</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Formation of rheumatoid pulmonary nodules during the leflunomide treatment</article-title>
          <source>Case Rep Clin Pract Rev</source>
          <year>2006</year>
          <volume>7</volume>
          <issue>2</issue>
          <fpage>139</fpage>
          <lpage>142</lpage>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yachoui</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ward</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kreidy</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>A rheumatoid nodule in an unusual location: mediastinal lymph node</article-title>
          <source>BMJ Case Rep</source>
          <year>2013</year>
          <fpage>2013</fpage>
          <lpage>2013</lpage>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rozin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yigla</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Guralnik</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Keidar</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Vlodavsky</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rozenbaum</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Rheumatoid lung nodulosis and osteopathy associated with leflunomide therapy</article-title>
          <source>Clin Rheumatol</source>
          <year>2006</year>
          <volume>25</volume>
          <issue>3</issue>
          <fpage>384</fpage>
          <lpage>388</lpage>
          <pub-id pub-id-type="doi">10.1007/s10067-005-0024-1</pub-id>
          <pub-id pub-id-type="pmid">16211338</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article id="S01" article-type="translation" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Relato De Caso</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Forma&#xE7;&#xE3;o de m&#xFA;ltiplos n&#xF3;dulos pulmonares durante tratamento com leflunomida<xref ref-type="fn" rid="fn02">*</xref>
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Yoshikawa</surname>
            <given-names>Gilberto Toshikawa</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dias</surname>
            <given-names>George Alberto da Silva</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fujihara</surname>
            <given-names>Satomi</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Silva</surname>
            <given-names>Luigi Ferreira e</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cruz</surname>
            <given-names>Lorena de Britto Pereira</given-names>
          </name>
          <xref ref-type="aff" rid="aff7">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fuzii</surname>
            <given-names>Hellen Thais</given-names>
          </name>
          <xref ref-type="aff" rid="aff8">
<sup>4</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Koyama</surname>
            <given-names>Roberta Vilela Lopes</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">
<sup>1</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff5"><label>1</label>Professor(a) Assistente. Universidade Federal do Par&#xE1;, Bel&#xE9;m (PA) Brasil</aff>
      <aff id="aff6"><label>2</label>Graduando em Medicina. Universidade Federal do Par&#xE1;, Bel&#xE9;m (PA) Brasil</aff>
      <aff id="aff7"><label>3</label>Professora Auxiliar. Universidade Federal do Par&#xE1;, Bel&#xE9;m (PA) Brasil</aff>
      <aff id="aff8"><label>4</label>Professora Adjunta II. Universidade Federal do Par&#xE1;, Bel&#xE9;m (PA) Brasil</aff>
      <author-notes>
        <corresp id="c02"><bold>Endere&#xE7;o para correspond&#xEA;ncia:</bold> Gilberto Yoshikawa. Avenida Senador Lemos, 443, Edif&#xED;cio Village Executive, sala 908/909, CEP 66050-000, Bel&#xE9;m, PA, Brasil. Tel. 55 91 3241-7905. E-mail: <email>gyoshikawa@uol.com.br</email></corresp>
      </author-notes>
      <abstract>
        <p>O comprometimento pulmonar &#xE9; uma das manifesta&#xE7;&#xF5;es extra-articulares da artrite reumat&#xF3;ide e pode ser devido &#xE0; pr&#xF3;pria doen&#xE7;a ou secund&#xE1;rio &#xE0;s medica&#xE7;&#xF5;es utilizadas para seu tratamento. Este trabalho relata um caso de uma paciente de 60 anos de idade com diagn&#xF3;stico de artrite reumatoide que evoluiu com m&#xFA;ltiplos n&#xF3;dulos pulmonares durante o tratamento com leflunomida.</p>
      </abstract>
      <kwd-group>
        <kwd>Artrite reumatoide</kwd>
        <kwd>Imunossupressores</kwd>
        <kwd>N&#xF3;dulo reumatoide</kwd>
        <kwd>Pulm&#xE3;o</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <sec>
        <title>Introdu&#xE7;&#xE3;o</title>
        <p>A artrite reumatoide (AR) &#xE9; uma doen&#xE7;a autoimune de etiologia desconhecida, caracterizada por poliartrite sim&#xE9;trica, podendo evoluir com deformidade e destrui&#xE7;&#xE3;o das articula&#xE7;&#xF5;es.<sup>(</sup>
<xref rid="B01" ref-type="bibr">1</xref>
<sup>,</sup>
<xref rid="B02" ref-type="bibr">2</xref>
<sup>)</sup> Quando compromete outros &#xF3;rg&#xE3;os, a morbidade e a gravidade da doen&#xE7;a s&#xE3;o maiores, podendo diminuir a expectativa de vida em 5 a 10 anos.<sup>(</sup>
<xref rid="B01" ref-type="bibr">1</xref>
<sup>)</sup>
</p>
        <p>As primeiras manifesta&#xE7;&#xF5;es pulmonares foram descritas por Ellman e Ball,<sup>(</sup>
<xref rid="B03" ref-type="bibr">3</xref>
<sup>)</sup> que descreveram fibrose pulmonar difusa em tr&#xEA;s pacientes com AR. Desde ent&#xE3;o, v&#xE1;rios autores t&#xEA;m descrito a associa&#xE7;&#xE3;o entre as manifesta&#xE7;&#xF5;es pulmonares e a AR. Os fatores de risco para envolvimento pulmonar s&#xE3;o: meia-idade, sexo masculino, artrite erosiva grave, t&#xED;tulos elevados de fator reumat&#xF3;ide, presen&#xE7;a de n&#xF3;dulos subcut&#xE2;neos, tabagismo, predisposi&#xE7;&#xE3;o gen&#xE9;tica (HLA-DRB1) e outras manifesta&#xE7;&#xF5;es extra-articulares da AR.<sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>,</sup>
<xref rid="B05" ref-type="bibr">5</xref>
<sup>)</sup>
</p>
        <p>O envolvimento pulmonar &#xE9; uma complica&#xE7;&#xE3;o grave da AR e pode se manifestar como uma doen&#xE7;a das vias a&#xE9;reas superiores, doen&#xE7;a intersticial pulmonar, derrame pleural, bronquiolite obliterante, alveolite fibrosante, n&#xF3;dulos reumatoides pulmonares, bronquiectasia, s&#xED;ndrome de Caplan, hemorragia pulmonar, pneumonia em organiza&#xE7;&#xE3;o, vasculites e infec&#xE7;&#xF5;es pulmonares.<sup>(</sup>
<xref rid="B06" ref-type="bibr">6</xref>
<sup>-</sup>
<xref rid="B09" ref-type="bibr">9</xref>
<sup>)</sup>
</p>
      </sec>
      <sec>
        <title>Relato de caso</title>
        <p>Paciente branca, feminina, 60 anos, bibliotec&#xE1;ria, natural e procedente de Bel&#xE9;m (PA) com AR h&#xE1; aproximadamente 10 anos, de acordo com os crit&#xE9;rios do <italic>American College of Rheumatology</italic>/<italic>European League Against Rheumatism</italic> de 2010 para AR. Na ocasi&#xE3;o do diagn&#xF3;stico foi introduzido metotrexato, com aumento progressivo da dose at&#xE9; 15 mg/semana. Posteriormente, foi suspenso por intoler&#xE2;ncia gastrintestinal e, naquela ocasi&#xE3;o, optou-se pela introdu&#xE7;&#xE3;o da leflunomida (20 mg/dia) e deflazacorte (12 mg/dia). Durante esse per&#xED;odo, evoluiu com melhora do quadro articular e, por conta pr&#xF3;pria, reduziu a leflunomida para 20 mg em dias alternados. </p>
        <p>H&#xE1; 8 anos, ap&#xF3;s trauma em regi&#xE3;o tor&#xE1;cica, foi realizada radiografia de t&#xF3;rax como screening para suspeita de fratura, sendo observado um n&#xF3;dulo pulmonar localizado na base pulmonar direita. A radiografia de t&#xF3;rax antes da introdu&#xE7;&#xE3;o da leflunomida era normal. Baseando-se nesse achado, a paciente procurou um pneumologista, que prosseguiu na investiga&#xE7;&#xE3;o. Os exames complementares revelavam: hemograma sem altera&#xE7;&#xE3;o; VHS de 65 mm/h; transaminases e esc&#xF3;rias nitrogenadas normais; fator antinuclear negativo; PCR de 6,2 mg/l; sorologias para hepatites virais negativas; fator reumatoide positivo (443 UI/ml); anticorpo anticitoplasma de neutr&#xF3;filos perinuclear e citoplasm&#xE1;tico (p-ANCA e c-ANCA, do ingl&#xEA;s <italic>perinuclear </italic>e<italic> cytoplasmic antineutrophil cytoplasmic antibody</italic>) negativos em v&#xE1;rias ocasi&#xF5;es; broncoscopia normal com lavado broncoalveolar com aus&#xEA;ncia de bact&#xE9;rias pela bacterioscopia, culturas negativas e citologia onc&#xF3;tica com celularidade escassa e material com aspecto de aut&#xF3;lise. A TC de t&#xF3;rax mostrou m&#xFA;ltiplos n&#xF3;dulos pulmonares cavitados predominando em base pulmonar esquerda (<xref ref-type="fig" rid="f04">Figura 1</xref>). A bi&#xF3;psia de um n&#xF3;dulo perif&#xE9;rico evidenciou a presen&#xE7;a de processo inflamat&#xF3;rio agudo necr&#xF3;tico e supurativo. Nessa ocasi&#xE3;o, optou-se pelo acompanhamento cl&#xED;nico e radiol&#xF3;gico do caso. </p>
        <p>
<fig id="f04" orientation="portrait" position="float"><label>Figura 1.</label><caption><title>TC de t&#xF3;rax mostrando opacidades nodulares cavitadas.</title></caption><graphic xlink:href="1806-3713-jbpneu-41-03-00281-gf01-pt"/></fig>
</p>
        <p>Ap&#xF3;s cinco meses de acompanhamento dos n&#xF3;dulos pulmonares, a paciente evoluiu com dispneia aos grandes esfor&#xE7;os acompanhada de tosse seca, sem febre. Uma nova broncoscopia evidenciou laringite e um n&#xF3;dulo na prega vocal direita. O aspecto endosc&#xF3;pico da &#xE1;rvore traqueobr&#xF4;nquica era normal; o lavado broncoalveolar apresentou pesquisa de BAAR negativa, bacterioscopia com frequentes bacilos gram-negativos (a cultura automatizada isolou <italic>Klebsiella</italic> pneumoniae e <italic>Pseudomonas</italic> fluorescens), as culturas para micobact&#xE9;rias e fungos foram negativas, e a citologia onc&#xF3;tica indicou aus&#xEA;ncia de c&#xE9;lulas neopl&#xE1;sicas. Naquela ocasi&#xE3;o, foi institu&#xED;da antibioticoterapia com clindamicina e fluconazol. Ap&#xF3;s broncoscopia com culturas negativas, introduziu-se prednisona (40 mg/dia) na tentativa de estabilizar o quadro. Entretanto, apesar da terap&#xEA;utica institu&#xED;da, nova TC de t&#xF3;rax evidenciou aumento dos n&#xF3;dulos pulmonares (<xref ref-type="fig" rid="f05">Figura 2</xref>). Nesse momento, a paciente foi encaminhada para S&#xE3;o Paulo para avalia&#xE7;&#xE3;o. Foi repetida a bi&#xF3;psia pulmonar (<xref ref-type="fig" rid="f06">Figura 3</xref>) por videotoracoscopia, que demonstrou les&#xE3;o inflamat&#xF3;ria cr&#xF4;nica, com centro exsudativo, em continuidade ao par&#xEA;nquima pulmonar (modificado por vasculite linfocit&#xE1;ria), assim como cavita&#xE7;&#xE3;o central preenchida por exsudato fibrinoleucocit&#xE1;rio e infiltrado linfocit&#xE1;rio com tecido de granula&#xE7;&#xE3;o ao redor. As pesquisas de BAAR e de fungos foram negativas; a pesquisa de c&#xE9;lulas neopl&#xE1;sicas foi negativa. Diante desse resultado, que afastou as hip&#xF3;teses de doen&#xE7;a neopl&#xE1;sica e infecciosa, optou-se pela suspens&#xE3;o da leflunomida. A corticoterapia sist&#xEA;mica foi mantida, e introduziu-se azatioprina (1 mg/kg/dia). Ap&#xF3;s seis meses da suspens&#xE3;o da leflunomida, os n&#xF3;dulos pulmonares desapareceram. At&#xE9; o momento, a paciente encontra-se fora de atividade de doen&#xE7;a, em uso de abatacepte (500 mg/m&#xEA;s) e sem corticoterapia sist&#xEA;mica h&#xE1; mais de um ano.</p>
        <p>
<fig id="f05" orientation="portrait" position="float"><label>Figura 2.</label><caption><title>TC de t&#xF3;rax mostrando opacidade nodular adjacente &#xE0; superf&#xED;cie pleural, localizada no lobo inferior direito.</title></caption><graphic xlink:href="1806-3713-jbpneu-41-03-00281-gf02-pt"/></fig>
</p>
        <p>
<fig id="f06" orientation="portrait" position="float"><label>Figura 3.</label><caption><title>Bi&#xF3;psia pulmonar. Em A, presen&#xE7;a de fibrina e col&#xE1;geno (seta vermelha), circundados por restos celulares (seta escura), com &#xE1;rea de necrose. Em B, presen&#xE7;a de infiltrado inflamat&#xF3;rio, com c&#xE9;lulas multinucleadas (seta escura) e presen&#xE7;a de necrose central.</title></caption><graphic xlink:href="1806-3713-jbpneu-41-03-00281-gf03-pt"/></fig>
</p>
      </sec>
      <sec>
        <title>Discuss&#xE3;o</title>
        <p>Os n&#xF3;dulos reumatoides pulmonares s&#xE3;o manifesta&#xE7;&#xF5;es extra-articulares da AR.<sup>(</sup>
<xref rid="B02" ref-type="bibr">2</xref>
<sup>,</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>)</sup> A preval&#xEA;ncia dos n&#xF3;dulos pulmonares varia: s&#xE3;o detectados pela radiografia de t&#xF3;rax em apenas 1% dos pacientes com AR, enquanto na TCAR de t&#xF3;rax s&#xE3;o identificados em at&#xE9; 20-22% e na bi&#xF3;psia pulmonar a c&#xE9;u aberto, em 32%.<sup>(</sup>
<xref rid="B07" ref-type="bibr">7</xref>
<sup>,</sup>
<xref rid="B10" ref-type="bibr">10</xref>
<sup>-</sup>
<xref rid="B12" ref-type="bibr">12</xref>
<sup>)</sup>
</p>
        <p>Eles podem ser &#xFA;nicos ou m&#xFA;ltiplos e variam de poucos mil&#xED;metros at&#xE9; 7 cm de di&#xE2;metro. Na maioria das vezes, s&#xE3;o assintom&#xE1;ticos ou produzem poucos sintomas pulmonares, embora possam causar tosse e escarros hemoptoicos, e tendem a comprometer ambos os pulm&#xF5;es. Localizam-se perifericamente, abaixo da pleura e podem escavar em aproximadamente um ter&#xE7;o dos casos, causando hemoptises, f&#xED;stulas broncopleurais, pneumot&#xF3;rax espont&#xE2;neo, infec&#xE7;&#xE3;o secund&#xE1;ria e abscesso.<sup>(</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>,</sup>
<xref rid="B10" ref-type="bibr">10</xref>
<sup>,</sup>
<xref rid="B13" ref-type="bibr">13</xref>
<sup>)</sup>
</p>
        <p>O aparecimento de n&#xF3;dulos pulmonares em pacientes com AR &#xE9; um problema diagn&#xF3;stico, e as possibilidades de neoplasia maligna e tuberculose devem ser afastadas.<sup>(</sup>
<xref rid="B10" ref-type="bibr">10</xref>
<sup>,</sup>
<xref rid="B13" ref-type="bibr">13</xref>
<sup>)</sup> Caracteristicamente, os n&#xF3;dulos que s&#xE3;o decorrentes de neoplasia pulmonar s&#xE3;o maiores que 10 mm de di&#xE2;metro e apresentam margens irregulares. Met&#xE1;stases tamb&#xE9;m podem aparecer como m&#xFA;ltiplos n&#xF3;dulos nos pulm&#xF5;es; por&#xE9;m, n&#xE3;o foi observada nenhuma neoplasia prim&#xE1;ria no caso relatado.<sup>(</sup>
<xref rid="B11" ref-type="bibr">11</xref>
<sup>,</sup>
<xref rid="B12" ref-type="bibr">12</xref>
<sup>,</sup>
<xref rid="B14" ref-type="bibr">14</xref>
<sup>)</sup>
</p>
        <p>Outras possibilidades diagn&#xF3;sticas s&#xE3;o as infec&#xE7;&#xF5;es por micobact&#xE9;rias e fungos, que podem se manifestar como n&#xF3;dulos; contudo, a aus&#xEA;ncia de sintomas sist&#xEA;micos raramente &#xE9; observada.<sup>(</sup>
<xref rid="B11" ref-type="bibr">11</xref>
<sup>)</sup>
</p>
        <p>Um aspecto relevante no caso relatado &#xE9; que os n&#xF3;dulos pulmonares, provavelmente, estavam relacionados ao uso da leflunomida, pois existem v&#xE1;rios argumentos a favor dessa hip&#xF3;tese: a paciente em quest&#xE3;o tinha hist&#xF3;ria de AR de longa data, sem comprometimento pulmonar antes do tratamento com leflunomida; n&#xF3;dulos reumatoides pulmonares s&#xE3;o menos frequentes em mulheres que em homens; n&#xF3;dulos pulmonares isolados podem aparecer durante o tratamento com leflunomida; e existem relatos de n&#xF3;dulos reumatoides perif&#xE9;ricos e/ou pulmonares em pacientes em tratamento com leflunomida.<sup>(</sup>
<xref rid="B08" ref-type="bibr">8</xref>
<sup>,</sup>
<xref rid="B15" ref-type="bibr">15</xref>
<sup>,</sup>
<xref rid="B16" ref-type="bibr">16</xref>
<sup>)</sup>
</p>
      </sec>
    </body>
    <back>
      <fn-group>
        <fn id="fn02" fn-type="other">
          <label>*</label>
          <p>Trabalho realizado na Universidade Federal do Par&#xE1;, Bel&#xE9;m (PA) Brasil.</p>
        </fn>
        <fn id="fn03" fn-type="supported-by">
          <p>Apoio financeiro: Nenhum.</p>
        </fn>
      </fn-group>
    </back>
  </sub-article>
</article>
</pmc-articleset>
